Internationales Symposium „New Strategies Against Multiresistent Pathogens“ in Martinsried
Am 22. und 23. Februar veranstaltet das Bayerische Forschungsnetzwerk bayresq.net (Neue Strategien gegen multiresistente…
Am 22. und 23. Februar veranstaltet das Bayerische Forschungsnetzwerk bayresq.net (Neue Strategien gegen multiresistente…
Biotechnologie ist ein Bereich, auf den sich Ruanda gerade verstärkt spezialisieren möchte mit dem Ziel, sich zu einem a…
Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved C…
Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2023 and busi…
New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic,…
. New agreement to establish global commercial manufacturing capacity for Vaxcyte's PCV candidates, VAX-24 and VAX-31,…
. - Shatter-resistant injection vials maximize patient and production safety - Optional Velocity coating for outstanding…
Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract valued at more than EUR 11 mi…
Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules Comp…
Interview with TotalEnergies Fluids (TEF) ICM: Please present the activities of TotalEnergies Fluids in a few words.…